Biomarkers for selecting biologic therapies in asthma. [PDF]
Ther Adv Respir DisChiarella SE +4 more
europepmc +1 more source
Combined biologic therapy targeting B cells and eosinophils in relapsing multiple sclerosis and severe asthma: a case report of ofatumumab and mepolizumab. [PDF]
Front ImmunolZanghì A +4 more
europepmc +1 more source
Comment on: Eosinophilic granulomatosis with polyangiitis across the eosinophilic spectrum: from molecular mechanisms to practical differential diagnosis and targeted therapy. [PDF]
ReumatologiaKosałka-Węgiel J, Korkosz M.
europepmc +1 more source
Burden of eosinophilic granulomatosis with polyangiitis by disease phase and steroid-sparing effects of biologics: a real-world retrospective study in Europe. [PDF]
ERJ Open ResHwee J +5 more
europepmc +1 more source
Tezepelumab After Mepolizumab in Allergic Bronchopulmonary Mycosis: A Case Report. [PDF]
CureusOda N +7 more
europepmc +1 more source
Advance in biologics for chronic rhinosinusitis with nasal polyps. [PDF]
Front AllergyDi Y, Zeng R, Huang L, Wu Y, Wu Q.
europepmc +1 more source
More Than Five Years of Sustained Remission With Mepolizumab in Adolescent-Onset Eosinophilic Granulomatosis With Polyangiitis: A Case Report. [PDF]
CureusAraya T +4 more
europepmc +1 more source
Recent Developments in Monoclonal-Antibody-Based Biologic Therapy for Severe Refractory Eosinophilic Asthma. [PDF]
Antibodies (Basel)Walsh GM.
europepmc +1 more source
Clinical Remission and Its Determinants in Adult Severe Asthma Patients Receiving Biologic Therapy: A Retrospective Analysis. [PDF]
J Clin MedEdiger D +3 more
europepmc +1 more source